Blueprint MedicinesBPMC
那斯達克 · USD
0
0
(0%)
收盤 01/01 08:00 (UTC+8)
盤後
0
0
(0%)
01/01 08:00 (UTC+8)
Blueprint MedicinesBPMC
0
0
(0%)
財務數據
損益表
- 0.39
- 0.63
- 0.58
- 0.57
- 0.72
- 0.96
- 1.38
- 1.28
- 1.46
- 1.49
- -41.22
- 63.19
- -9.03
- -1.74
- 27.21
- 33.57
- 43.74
- -7.22
- 14.18
- 2.08
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | 2023/Q2 | 2023/Q1 | 2022/Q4 | |
營業收入淨額 | 149,413 | 146,366 | 128,185 | 138,157 | 96,116 | 71,957 | 56,566 | 57,570 | 63,287 | 38,781 |
營業成本 | 2,802 | 7,447 | 1,931 | 7,594 | 3,191 | 260 | 2,782 | 2,323 | 3,175 | 4,848 |
營業毛利 | 146,611 | 138,919 | 126,254 | 130,563 | 92,925 | 71,697 | 53,784 | 55,247 | 60,112 | 33,933 |
營業費用 | - | - | - | 173,609 | 171,748 | 176,806 | 182,764 | 183,228 | 184,319 | 183,732 |
研發費用 | 91,890 | 83,672 | 85,300 | 84,270 | 88,191 | 97,536 | 108,049 | 110,062 | 112,073 | 117,840 |
推銷及管理費用 | 95,807 | 96,450 | 89,926 | 89,339 | 83,557 | 79,270 | 74,715 | 73,166 | 72,246 | 65,892 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -41,086 | -41,203 | -48,972 | -43,046 | -78,823 | -105,109 | -128,980 | -127,981 | -124,207 | -149,799 |
其他收入及費用 | 461 | -306 | 586 | 18 | 174,034 | -577 | -728 | -627 | 986 | 1,429 |
利息費用 | 8,129 | 7,775 | 7,616 | 6,865 | 5,895 | -13,624 | 3,809 | -5,819 | - | -7,527 |
稅前純益 | 1,285 | -49,284 | -56,002 | -49,893 | 89,316 | -110,855 | -133,517 | -132,604 | -129,040 | -157,610 |
所得稅 | 789 | 672 | 272 | 102 | 180 | 61 | 197 | 190 | 520 | 1,036 |
稅後純益 | 496 | -49,956 | -56,274 | -49,995 | 89,136 | -110,916 | -133,714 | -132,794 | -129,560 | -158,646 |
基本每股稅後盈餘(元) | 0.01 | -0.79 | -0.89 | -0.80 | 1.45 | -1.82 | -2.20 | -2.19 | -2.15 | -2.65 |
稀釋每股稅後盈餘(元) | 0.01 | -0.80 | -0.88 | -0.79 | 1.40 | -1.82 | -2.20 | -2.20 | -2.15 | -2.65 |
基本平均股數(千股) | 64096.00 | 63600.00 | 63381.00 | 62854.00 | 61580.00 | 60890.00 | 60688.00 | 60516.00 | 60126.00 | 59873.00 |
稀釋平均股數(千股) | 66526.00 | 63600.00 | 63381.00 | 62854.00 | 63802.00 | 60890.00 | 60688.00 | 60516.00 | 60126.00 | 59873.00 |
還原基本每股稅後盈餘(元) | 0.01 | -0.79 | -0.89 | -0.80 | 1.45 | -1.82 | -2.20 | -2.19 | -2.15 | -2.65 |
還原稀釋每股稅後盈餘(元) | 0.01 | -0.80 | -0.88 | -0.79 | 1.40 | -1.82 | -2.20 | -2.20 | -2.15 | -2.65 |
還原基本平均股數(千股) | 64,096 | 63,600 | 63,381 | 62,854 | 61,580 | 60,890 | 60,688 | 60,516 | 60,126 | 59,873 |
還原稀釋平均股數(千股) | 66,526 | 63,600 | 63,381 | 62,854 | 63,802 | 60,890 | 60,688 | 60,516 | 60,126 | 59,873 |
EBITDA(千元) | 10,541 | -42,801 | -50,857 | -45,056 | 94,828 | -128,887 | -132,273 | -132,465 | -125,356 | -159,947 |